Home Contact Sitemap

PedAM

Pediatric Disease Annotations & Medicines




Disease peripheral vascular disease
Symptom C1456822|claudication
Sentences 9
PubMedID- 23162186 3 cilostazol has been used as an antiplatelet agent and in intermittent claudication in patients with peripheral vascular disease.
PubMedID- 25740905 The presentation of congenital popliteal artery stenosis is very similar to that in peripheral vascular disease, with intermittent claudication, slow healing wounds and transitory change in skin colour and temperature 5.
PubMedID- 23767943 Objectives: pentoxifylline, a methylxanthine derivative with significant hemorheologic properties, is used for claudication in patients with peripheral vascular disease, and experimentally for ischemic injury to organs because of its antioxidant and antiinflammatory effects.
PubMedID- 25044117 Cilostazol (6-4-(1-cyclohexyl-1h-tetrazol-5-yl)butoxy-3,4-dihydro-2-(1h)-quinolinone) is a medication approved by the us food and drug administration and used in the alleviation of the symptom of intermittent claudication in individuals with peripheral vascular disease.
PubMedID- 21640657 The limitation in mobility should not clearly be a result of otherwise defined specific diseases of muscle, peripheral vascular disease with intermittent claudication, central and peripheral nervous system disorders, or cachexia.
PubMedID- 26064987 Cilostazol is a phosphodiesterase iii inhibitor used to relieve symptoms of claudication in patients with peripheral vascular disease.
PubMedID- 26203244 It also suppresses platelet aggregation and is a direct arterial vasodilator.10 czl is a medication used in the alleviation of the symptom of intermittent claudication in individuals with peripheral vascular disease.
PubMedID- 20668717 She has peripheral vascular disease with claudication after walking 100 meters but did not require vascular intervention.
PubMedID- 24711696 Bbs may cause acute cardiac decompensation in elderly patients with congestive heart failure, intermittent claudication in patients with peripheral vascular disease, and bronchoconstriction in patients with chronic obstructive pulmonary disease.

Page: 1